Glucaric acid

Glucaric acid is a lipid of Fatty Acyls (FA) class. Glucaric acid is associated with abnormalities such as Consumption-archaic term for TB and furuncle. The involved functions are known as Oxidation, Mutation, Process, Cell Growth and Anabolism. Glucaric acid often locates in BL21, Clone and host. The associated genes with Glucaric acid are MIOX gene, ISYNA1 gene, Genome and Candidate Disease Gene. The related experimental models are Knock-out.

Cross Reference

Introduction

To understand associated biological information of Glucaric acid, we collected biological information of abnormalities, associated pathways, cellular/molecular locations, biological functions, related genes/proteins, lipids and common seen animal/experimental models with organized paragraphs from literatures.

What diseases are associated with Glucaric acid?

Glucaric acid is suspected in and other diseases in descending order of the highest number of associated sentences.

Related references are mostly published in these journals:

Disease Cross reference Weighted score Related literature
Loading... please refresh the page if content is not showing up.

Possible diseases from mapped MeSH terms on references

We collected disease MeSH terms mapped to the references associated with Glucaric acid

MeSH term MeSH ID Detail
Critical Illness D016638 13 associated lipids
Hypercalcemia D006934 13 associated lipids
Peritoneal Neoplasms D010534 16 associated lipids
Tuberculosis, Pulmonary D014397 18 associated lipids
Drug Hypersensitivity D004342 20 associated lipids
Esophageal Neoplasms D004938 20 associated lipids
Myocardial Reperfusion Injury D015428 20 associated lipids
Heart Defects, Congenital D006330 20 associated lipids
Myocardial Infarction D009203 21 associated lipids
Anemia D000740 21 associated lipids
Per page 10 20 50 100 | Total 85

PubChem Associated disorders and diseases

What pathways are associated with Glucaric acid

Lipid pathways are not clear in current pathway databases. We organized associated pathways with Glucaric acid through full-text articles, including metabolic pathways or pathways of biological mechanisms.

Related references are published most in these journals:

Pathway name Related literatures
Loading... please refresh the page if content is not showing up.

PubChem Biomolecular Interactions and Pathways

Link to PubChem Biomolecular Interactions and Pathways

What cellular locations are associated with Glucaric acid?

Related references are published most in these journals:

Location Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

What functions are associated with Glucaric acid?


Related references are published most in these journals:

Function Cross reference Weighted score Related literatures

What lipids are associated with Glucaric acid?

There are no associated biomedical information in the current reference collection.

What genes are associated with Glucaric acid?

Related references are published most in these journals:


Gene Cross reference Weighted score Related literatures

What common seen animal models are associated with Glucaric acid?

Knock-out

Knock-out are used in the study 'Evolution-guided optimization of biosynthetic pathways.' (Raman S et al., 2014).

Related references are published most in these journals:

Model Cross reference Weighted score Related literatures
Loading... please refresh the page if content is not showing up.

NCBI Entrez Crosslinks

All references with Glucaric acid

Download all related citations
Per page 10 20 50 100 | Total 1061
Authors Title Published Journal PubMed Link
Li H and Wang SX [Intravenous iron sucrose in maintenance dialysis patients with renal anemia: a clinical study]. 2009 Zhonghua Yi Xue Za Zhi pmid:19567093
Jung K et al. [D-glucaric acid excretion in kidney transplant patients as an indicator of microsomal enzyme capacity]. 1982 Z Urol Nephrol pmid:6126971
Schröder O et al. A study for the evaluation of safety and tolerability of intravenous high-dose iron sucrose in patients with iron deficiency anemia due to gastrointestinal bleeding. 2004 Z Gastroenterol pmid:15314711
Giger M and Achermann R [Iron substitution in outpatients in Switzerland: Increase of costs associated with intravenous administration]. 2013 Z Evid Fortbild Qual Gesundhwes pmid:23916272
Kaizu T [Non-dialyzable beta-glucuronidase inhibitor in guinea-pig urine. I. Purification (author's transl)]. 1975 Yakugaku Zasshi pmid:1238533
Hasegawa K et al. [Improvement of urinary d-glucaric acid assay and its application]. 2008 Yakugaku Zasshi pmid:18176065
Warrander A and Waring RH An improved method for gas chromatographic determination of urinary xylitol and glucuronic, glucaric gulonic and ascorbic acids, with their values in the rat, rabbit, guinea-pig and marmoset. 1978 Xenobiotica pmid:102085
Mori M et al. Urinary and biliary metabolites of mephentermine in male Wistar rats. 1989 Xenobiotica pmid:2665325
Layiwola PJ et al. Hydrolysis of the biliary glucuronic acid conjugate of phenol by the intestinal mucus/flora of goldfish (Carassius auratus). 1983 Xenobiotica pmid:6858197
Lake BG et al. The excretion of metabolites of the D-glucuronic acid pathway in human urine. Effect of phenobarbitone administration. 1982 Xenobiotica pmid:7113260
Brunelle FM and Verbeeck RK Glucuronidation of diflunisal in liver and kidney microsomes of rat and man. 1996 Xenobiotica pmid:8867997
Hong SK and Rankin GO Biotransformation of 2-chloroaniline in the Fischer 344 rat: identification of urinary metabolites. 1998 Xenobiotica pmid:9849645
Marselos M et al. Responses of the D-glucuronic acid pathway in rat tissues to treatment with tetrachlorodibenzodioxin. 1978 Xenobiotica pmid:685288
Muñoz M et al. Intravenous iron in inflammatory bowel disease. 2009 World J. Gastroenterol. pmid:19787830
Lutz W and Kralkowska E [Laboratory diagnosis of subclinical forms of chemically-induced liver damage]. 1986 Wiad. Lek. pmid:2873689
García-Erce JA et al. Efficacy of preoperative recombinant human erythropoietin administration for reducing transfusion requirements in patients undergoing surgery for hip fracture repair. An observational cohort study. 2009 Vox Sang. pmid:19497085
Birgegård G et al. High incidence of iron depletion and restless leg syndrome (RLS) in regular blood donors: intravenous iron sucrose substitution more effective than oral iron. 2010 Vox Sang. pmid:20598107
Bespalov VG and Aleksandrov VA [Anticarcinogenic effect of potassium salts of glucaric and glucuronic acid in induced models of cervical and esophageal tumors]. 2012 Vopr Onkol pmid:23607211
Düllmann J et al. [Iron storage and metabolism in nacrophages and endothelial cells after intravenous administration of colloidal ferric saccharate in man]. 1976 Verh Anat Ges pmid:1024396
Montano-Pedroso JC et al. Postoperative intravenously administered iron sucrose versus postoperative orally administered iron to treat post-bariatric abdominoplasty anaemia (ISAPA): the study protocol for a randomised controlled trial. 2016 Trials pmid:27068478
Rowlands M et al. The effect of intravenous iron on postoperative transfusion requirements in hip fracture patients: study protocol for a randomized controlled trial. 2013 Trials pmid:24015990
Breborowicz A et al. Iron sucrose induced morphological and functional changes in the rat kidney. 2006 Transl Res pmid:17145571
Breborowicz A et al. Peritoneal effects of intravenous iron sucrose administration in rats. 2007 Transl Res pmid:17543848
Roth S et al. Comparative toxicity and cell-tissue distribution study on nanoparticular iron complexes using avian embryos and HepG2-cells. 2008 Transl Res pmid:18061126
Picker SM et al. Effects of Mirasol PRT treatment on storage lesion development in plasma-stored apheresis-derived platelets compared to untreated and irradiated units. 2008 Transfusion pmid:18513255
Cuenca J et al. Patients with pertrochanteric hip fracture may benefit from preoperative intravenous iron therapy: a pilot study. 2004 Transfusion pmid:15383017
Serrano-Trenas JA et al. Role of perioperative intravenous iron therapy in elderly hip fracture patients: a single-center randomized controlled trial. 2011 Transfusion pmid:20630042
Auerbach M et al. The role of intravenous iron in anemia management and transfusion avoidance. 2008 Transfusion pmid:18346021
Weisbach V et al. Oral or intravenous iron as an adjuvant to autologous blood donation in elective surgery: a randomized, controlled study. 1999 Transfusion pmid:10335995
García-Erce JA et al. Perioperative intravenous iron preserves iron stores and may hasten the recovery from post-operative anaemia after knee replacement surgery. 2006 Transfus Med pmid:16999756
Muñoz M et al. Role of parenteral iron in transfusion requirements after total hip replacement. A pilot study. 2006 Transfus Med pmid:16623920
Meier JR et al. Urine mutagenicity and biochemical effects of the drinking water mutagen, 3-chloro-4-(dichloromethyl)-5-hydroxy-2[5H]-furanone (MX), following repeated oral administration to mice and rats. 1996 Toxicology pmid:8658560
Oredipe OA et al. Dietary glucarate-mediated inhibition of initiation of diethylnitrosamine-induced hepatocarcinogenesis. 1992 Toxicology pmid:1519243
Gupta KP and Singh J Modulation of carcinogen metabolism and DNA interaction by calcium glucarate in mouse skin. 2004 Toxicol. Sci. pmid:14976333
Apostoli P et al. Relationship between PCBs in blood and D-glucaric acid in urine. 2003 Toxicol. Lett. pmid:12919720
Bhattacharya S et al. D-saccharic acid-1,4-lactone ameliorates alloxan-induced diabetes mellitus and oxidative stress in rats through inhibiting pancreatic β-cells from apoptosis via mitochondrial dependent pathway. 2011 Toxicol. Appl. Pharmacol. pmid:21982801
Bhattacharya S et al. D-saccharic acid 1,4-lactone protects diabetic rat kidney by ameliorating hyperglycemia-mediated oxidative stress and renal inflammatory cytokines via NF-κB and PKC signaling. 2013 Toxicol. Appl. Pharmacol. pmid:23261973
Tiwari P and Gupta KP Modulation of miR-203 and its regulators as a function of time during the development of 7, 12 dimethylbenz [a] anthracene induced mouse skin tumors in presence or absence of the antitumor agents. 2014 Toxicol. Appl. Pharmacol. pmid:24792773
Edelson SB and Cantor DS Autism: xenobiotic influences. 1998 Nov-Dec Toxicol Ind Health pmid:9891912
Hanaue H et al. Estimation of the functional reserve of the human liver by urinary D-glucaric acid excretion after vitamin C administration. 1993 Tokai J. Exp. Clin. Med. pmid:7940601
Matsuoka S et al. Correlation between the level of urinary D-glucaric acid and the degree of activation of masked compound (FT-207) in cancer patients. 1981 Tohoku J. Exp. Med. pmid:6797104
Tanno Y and Takishima T Enhancing effect of saccharated ferric oxide on human lymphocyte transformation in serum-free medium. 1982 Tohoku J. Exp. Med. pmid:7101280
Moore KL et al. Uncommon adverse effect of a common medication. 2013 Tidsskr. Nor. Laegeforen. pmid:23344600
Freche JP et al. [Variation in the urinary excretion of 6-beta-hydroxycortisol in humans after administration of the new isoquinoline derivative, PK-11195 (52028 RP)]. 1989 Sep-Oct Therapie pmid:2573163
Wood DM et al. Hepatocellular damage following therapeutic intravenous iron sucrose infusion in a child. 2005 Ther Drug Monit pmid:16044093
Rangel EB et al. Labile plasma iron generation after intravenous iron is time-dependent and transitory in patients undergoing chronic hemodialysis. 2010 Ther Apher Dial pmid:20438541
Pasquini R et al. Thioethers, mutagens, and D-glucaric acid in urine of operating room personnel exposed to anesthetics. 1989 Teratog., Carcinog. Mutagen. pmid:2576815
Young RS Determination of calcium oxide in calcined phosphate ores. 1973 Talanta pmid:18961359
Torres-Corzo JG et al. Comparison of cerebrospinal fluid obtained by ventricular endoscopy and by lumbar puncture in patients with hydrocephalus secondary to neurocysticercosis. 2009 Surg Neurol pmid:19249584
Janus N et al. Administration of intravenous iron complexes on implantable central venous access port in cancer patients in France: the FERPAC survey. 2013 Support Care Cancer pmid:23715817